Mentzer Index for Differentiating Iron Deficiency Anemia from Thalassemia Trait
Definition and Calculation
The Mentzer index is calculated as MCV (in fL) divided by RBC count (in millions per microliter), with a value >13 indicating iron deficiency anemia and a value <13 suggesting thalassemia trait. 1
- This simple discriminatory index uses only two parameters from a standard complete blood count, making it accessible even in resource-limited settings where advanced testing may not be readily available 1, 2
- The index exploits the fundamental difference between these two microcytic anemias: thalassemia trait produces marked microcytosis with elevated or normal RBC counts, while iron deficiency produces microcytosis with reduced RBC counts 2
Diagnostic Performance
The Mentzer index demonstrates sensitivity of 91% and specificity of 83% for iron deficiency anemia, with corresponding values of 83% sensitivity and 91% specificity for beta-thalassemia trait. 1
- In comparative studies, the Mentzer index correctly identified 94.71% of patients, performing better than most other discriminatory indices including England-Fraser, Srivastava, and RBC count alone 3
- The Youden's index (a measure of overall diagnostic accuracy) for Mentzer was 90.1, ranking it as the best performing discriminatory index among commonly used formulas 3
- When applied to blood donors with microcytosis, the Mentzer index was the only index achieving both sensitivity and specificity above 80% for differentiating both conditions 2
Clinical Application Algorithm
Apply the Mentzer index only to patients with confirmed microcytic (MCV <72 fL) and hypochromic (MCHC <32 g/L) anemia, as calculating it on all anemic patients without these criteria reduces diagnostic accuracy. 4
Step-by-step approach:
Confirm microcytic hypochromic anemia on complete blood count before calculating the index 4
Calculate Mentzer index = MCV ÷ RBC count 1
Interpret the result:
Consider ethnic background: In populations where thalassemia is common, hemoglobin electrophoresis is recommended for all patients with microcytosis and normal iron studies to prevent unnecessary gastrointestinal investigation 6
Critical Limitations and Pitfalls
The Mentzer index is a screening tool only and must always be confirmed with definitive testing—serum ferritin for iron deficiency or hemoglobin electrophoresis for thalassemia trait. 1, 2
False positives occur: The index has 17% false positive rate for iron deficiency and 9% false positive rate for thalassemia, meaning definitive testing is mandatory before treatment decisions 1
Combined deficiency states reduce accuracy: When iron deficiency and thalassemia trait coexist (occurring in 8% of microcytic cases), the Mentzer index may misclassify the patient 2
Inflammation confounds interpretation: Since ferritin is an acute phase reactant, apparently normal ferritin levels (up to 100 μg/L) may still represent iron deficiency in patients with concurrent inflammation, malignancy, or hepatic disease 6
Do not use the index alone to guide iron supplementation: In patients with confirmed thalassemia trait, chronic iron supplementation beyond correction of documented deficiency risks iron overload, as thalassemia carriers do not benefit from ongoing iron therapy 5
Integration with Guideline-Recommended Workup
When microcytosis is identified with normal iron studies (ferritin >45 μg/L), hemoglobin electrophoresis is recommended to prevent unnecessary gastrointestinal investigation, particularly in patients of appropriate ethnic background. 6
The British Society of Gastroenterology emphasizes that thalassemia typically produces MCV reduced out of proportion to the degree of anemia, a pattern the Mentzer index helps identify 6
If thalassemia trait is confirmed, provide genetic counseling and recommend partner screening if family planning is relevant 5
If iron deficiency is confirmed (ferritin <15 μg/L is highly specific with 99% specificity, or <30 μg/L indicating low stores), initiate therapeutic iron supplementation at 3-6 mg/kg/day of elemental iron and reassess after 8-12 weeks 5, 7
Document the thalassemia diagnosis clearly in the medical record to prevent unnecessary future iron supplementation once any coexisting iron deficiency is corrected 5